Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Conference Agenda

Keynote Sessions
08:30 - 09:00
Create the value that defines you
  • Determine how your medicines will be evaluated in the future and how value will be shared with stakeholders
  • Get your priorities right – how will your focus on health solutions and outcomes generate commercial results?
  • Strengthen reputation through a more open, human approach and a relentless focus on innovation
  • Guarantee access in challenging markets and ensure your products are accessible to those most in need
09:00 - 09:30
Be the ultimate guide
  • The trusted source – how, why and where your company should be viewed as a credible hub for medical knowledge
  • Align around patient insights and use these to forge deeper stakeholder relationships and regain trust
  • Beyond transparency – ideas to repair relationships and regain trust in the information we provide
  • Identify the changing customer landscape and ensure you have the processes in place to meet HCP and patient needs
09:30 - 10:00
The future of healthcare is… us
  • Be the solution – how your company can find new assets and skills, whether in-house or through partnership, to deliver genuine healthcare innovations
  • Understand the ultimate role of digital in delivering true integrated care and providing deeper understanding of patient and customer journeys
  • In data we trust – understand healthcare’s long-term disruption beyond today’s revolution in combined analytics and digital tech
  • Engineer a culture which embraces digital uptake and acknowledges your shared vision of healthcare delivery
09:30 - 10:00

Speakers Include:

  • Joaquin Duato, WorldWide Chairman, Pharmaceuticals, Johnson & Johnson
  • Sebastian Guth, Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals
  • Christi Shaw, Senior Vice President & President, Lilly Bio Medicines
  • Rob Koremans, CEO & President, TEVA Specialty Medicines
  • Paul Perreault, CEO, CSL Limited
  • Giles Platford, Presdient, Europe and Canada Business Unit, Takeda
  • Andrin Oswald, Director – Life Sciences Partnerships, Global Health, Gates Foundation
  • Kabir Nath, President & CEO, Otsuka USA
  • Julie Gerberding, EVP & Chief Patient Officer, MSD
  • Nathalie Moll, Director General, EFPIA
  • Milind Kamkolkar, Chief Data Officer, Sanofi
  • Mark Mallon, EVP, Global Product and Portfolio Strategy, AstraZeneca
  • Andrew Baum, Managing Director Global Head of Healthcare Research, Citi
  • Ameet Nathwani, EVP & Chief Medical Officer, Sanofi
  • William H. Carson, President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.
  • Bahija Jallal, Executive Vice-President, MedImmune
  • Alfredo Barón de Juan, EVP Global Commercial Operations, Almirall
  • Dr. Carey Adams, CEO, UICC
  • Jean-Luc Eiselé, CEO, World Heart Foundation
  • Bryon Matthews, President and CEO, Miller Heiman Group
PROVIDE BUSINESS-CRITICAL VALUE THROUGH MEDICAL AFFAIRS
00:00
-
00:00
The evolution of Medical as the mission-critical function
  • Embrace the medical solution for your company’s vision of the future
  • See the value of your medical contributions to global strategic decisions
  • Identify where medical leadership can bring added value to your company

Speaker Logo Mark Mallon Executive Vice President, Global Medical Affairs, Global Product and Portfolio Strategy AstraZeneca

00:00
-
00:00
The Perfect Storm: the external winds of change propelling Medical to the forefront of business strategy
  • How medical can spearhead the response to value-based customer decisions
  • Offer the scientific depth, which other functions cannot, to satisfy payer demands for knowledge
  • Align your medical team with the requirements of regulators that can only be satisfied through medical leadership

Sanofi Antonio Tataranni Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit Sanofi

00:00
-
00:00
PANEL: Move past the metrics: ensure your primary objective is driving external value through business ownership
  • How to change the Medical culture to one of business ownership where metrics are the means to driving external value, not the objective
  • Improve customer experience and gain internal recognition as a bi-product of bringing external value
  • Where do we go from here? How can Medical evolve as the strategic partner to internal functions, while maintaining its role as the scientific partner of the customer

Speaker Logo Thomas D’Hooghe Vice-President and Head Global Medical Affairs Fertility Merck

Speaker Logo Hubert Bland Country Medical Chair and Medical Head Diabetes and Cardiovascular Sanofi

Speaker Logo Ludovic Hacopian Worldwide MSL and Field Effectiveness Head BMS

Speaker Logo Emma Booth European Medical Head of Strategy and Operations Amgen

00:00
-
00:00
Maintain your external authenticity as your internal importance increases
  • Fuse your new strategic role with the scientific base that has already incurred increasing Medical influence
  • Bring together internal functions and destroy silos to devise strategy that is in the best interests of the patient
  • Evolve medical through increased external interaction and improve the image of pharma as a consequence

Speaker Logo Monica de Abadal Vice President Global Medical Affairs Services Ipsen

00:00
-
00:00
A flexible and pragmatic Medical operating model to amplify stakeholder value
  • Build a framework that achieves global and regional objectives on a country level, allowing for flexibility and local tailoring
  • Maximise external value: prioritise projects that will make the biggest difference to external stakeholder
  • Centre your new strategy around core strengths that will bring the best out of your Medical team

Speaker Logo Mauricio Silva de Lima VP Head of Medical Affairs Europe Roche

00:00
-
00:00
ROUNDTABLE DISCUSSIONS
  1. Determine the best place for Medical to sit. Under commercial, under clinical or by itself?
  2. What are the skills and expertise needed to face new Med Affairs objectives and challenges?
  3. Gaining drug approval: Is real-world the real deal?
  4. How to best communicate your data to external stakeholders and gain insights in return
  5. What does AI offer Medical in the future?
  6. How to maintain MSL authenticity under commercial pressures
ACHIEVING VALUE: DATA INSIGHTS AND REAL-WORLD INFLUENCE
00:00
-
00:00
From volume to valued data: collect evidence in the most effective way
  • Develop an outcome-orientated model for data collection and analysis
  • Shift your mindset from ‘deterministic to probabilistic’ and fall in line with clinical intervention procedures
  • Learn how another industry drives success with effective data analysis and performance

Speaker Logo Adam Hill Chief Medical Officer McLaren

00:00
-
00:00
The future of Real-World Evidence: optimising outcomes
  • Responding to a regulatory model that will gain earlier approval with less data from phase 3
  • Use real-world data to plan your route to a value-based healthcare system
  • Be more efficient in your research studies

Speaker Logo Mike Spencer Head of RWE, EMEA Janssen

00:00
-
00:00
Use digital to bring you closer to external stakeholders with data collection and dissemination
  • Gather real-time patient data for the most reliable study results
  • Communicate your data to HCPs and KOLs most effectively for maximum external engagement
  • Use digital platforms to share patient data with your colleagues in a compliant way

Speaker Logo Felix Jackson Founder medCrowd

MSLS: PARTNERS TO PHARMA, PHYSICIANS AND PATIENTS
00:00
-
00:00
Turn your MSLs into Medical Science Leaders
  • Identify the best candidates when recruiting the external faces of your brand
  • Upgrade your MSL team with developed business skills to complement their medical knowledge
  • See how a leading medical company have developed their MSL Centre of Excellence to instil a culture of quality

Speaker Logo Martina Muttke Head of International Affairs Shire

00:00
-
00:00
PANEL: Continue to build trust between pharma and physicians through evidence based interactions
  • Keep your MSLs on-message in off-label discussions to collect core insights from wide ranging discussions
  • Teach your MSLs how to create open and frank dialogues with KOLs and HCPs that will lead to the most productive conversations
  • Gain a strategic advantage before market access by discussing drugs in clinical phases to understand what the market needs

Speaker Logo Kumaran Krishnan Associate Director MSL and Digital Transformation Teva

Speaker Logo Gundula Schneidewind Managing Director Belgium Takeda

Speaker Logo David Montgomery Vice President Global Science Exchange Pfizer Oncology

00:00
-
00:00
Own the Medical Narrative and drive partnership
  • Understand the evolution of measures of Field Medical value; from counting calls to unlocking the true value of MSL relations through qualitative methods
  • Create a cohesive framework that inspires your MSLs to deliver on global visions through differing, country dependent methods
  • Elevate the status of field medical from resource to strategic partner.

Speaker Logo Victoria Ho WW Field Medical & Communications Lead Bristol-Myers Squibb

00:00
-
00:00
*The “value” of Medical Affairs to the medical community*
  • Create a ‘value-added service’ for physicians through exclusively medical activities
  • Bring value to both customers and clinicians though enhanced communication processes
  • Build valuable partnerships where medical can have a leading role in the long term

Speaker Logo Pam Bacon Executive Director Medical Affairs Celgene

00:00
-
00:00
Think Globally, Act Locally: Build your big picture one pixel at a time
  • Develop a Medical team that can understand their role in the global vision of the company
  • Give your team freedom to act depending on local issues to be most effective in their region
  • Align your team as a strategic partner from top to bottom to become a true mission-critical function

Sanofi Sandra Silvestri Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit Sanofi

00:00
-
00:00
Promoting the patient voice in evidence generation and global market access planning
  • Overview of real-world challenges and considerations for use
  • Regulator and payer perspectives on patient-centric data in decision-making
  • Highly successful strategies for leveraging the patient voice in RWE research

Speaker Logo Parexel

Keynote Sessions
08:30 - 09:00
Create the value that defines you
  • Determine how your medicines will be evaluated in the future and how value will be shared with stakeholders
  • Get your priorities right – how will your focus on health solutions and outcomes generate commercial results?
  • Strengthen reputation through a more open, human approach and a relentless focus on innovation
  • Guarantee access in challenging markets and ensure your products are accessible to those most in need
09:00 - 09:30
Be the ultimate guide
  • The trusted source – how, why and where your company should be viewed as a credible hub for medical knowledge
  • Align around patient insights and use these to forge deeper stakeholder relationships and regain trust
  • Beyond transparency – ideas to repair relationships and regain trust in the information we provide
  • Identify the changing customer landscape and ensure you have the processes in place to meet HCP and patient needs
09:30 - 10:00
The future of healthcare is… us
  • Be the solution – how your company can find new assets and skills, whether in-house or through partnership, to deliver genuine healthcare innovations
  • Understand the ultimate role of digital in delivering true integrated care and providing deeper understanding of patient and customer journeys
  • In data we trust – understand healthcare’s long-term disruption beyond today’s revolution in combined analytics and digital tech
  • Engineer a culture which embraces digital uptake and acknowledges your shared vision of healthcare delivery
09:30 - 10:00

Speakers Include:

  • Joaquin Duato, WorldWide Chairman, Pharmaceuticals, Johnson & Johnson
  • Sebastian Guth, Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals
  • Christi Shaw, Senior Vice President & President, Lilly Bio Medicines
  • Rob Koremans, CEO & President, TEVA Specialty Medicines
  • Paul Perreault, CEO, CSL Limited
  • Giles Platford, Presdient, Europe and Canada Business Unit, Takeda
  • Andrin Oswald, Director – Life Sciences Partnerships, Global Health, Gates Foundation
  • Kabir Nath, President & CEO, Otsuka USA
  • Julie Gerberding, EVP & Chief Patient Officer, MSD
  • Nathalie Moll, Director General, EFPIA
  • Milind Kamkolkar, Chief Data Officer, Sanofi
  • Mark Mallon, EVP, Global Product and Portfolio Strategy, AstraZeneca
  • Andrew Baum, Managing Director Global Head of Healthcare Research, Citi
  • Ameet Nathwani, EVP & Chief Medical Officer, Sanofi
  • William H. Carson, President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.
  • Bahija Jallal, Executive Vice-President, MedImmune
  • Alfredo Barón de Juan, EVP Global Commercial Operations, Almirall
  • Dr. Carey Adams, CEO, UICC
  • Jean-Luc Eiselé, CEO, World Heart Foundation
  • Bryon Matthews, President and CEO, Miller Heiman Group

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

PROVIDE BUSINESS-CRITICAL VALUE THROUGH MEDICAL AFFAIRS
00:00
-
00:00
The evolution of Medical as the mission-critical function
  • Embrace the medical solution for your company’s vision of the future
  • See the value of your medical contributions to global strategic decisions
  • Identify where medical leadership can bring added value to your company

Speaker Logo Mark Mallon Executive Vice President, Global Medical Affairs, Global Product and Portfolio Strategy AstraZeneca

00:00
-
00:00
The Perfect Storm: the external winds of change propelling Medical to the forefront of business strategy
  • How medical can spearhead the response to value-based customer decisions
  • Offer the scientific depth, which other functions cannot, to satisfy payer demands for knowledge
  • Align your medical team with the requirements of regulators that can only be satisfied through medical leadership

Sanofi Antonio Tataranni Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit Sanofi

00:00
-
00:00
PANEL: Move past the metrics: ensure your primary objective is driving external value through business ownership
  • How to change the Medical culture to one of business ownership where metrics are the means to driving external value, not the objective
  • Improve customer experience and gain internal recognition as a bi-product of bringing external value
  • Where do we go from here? How can Medical evolve as the strategic partner to internal functions, while maintaining its role as the scientific partner of the customer

Speaker Logo Thomas D’Hooghe Vice-President and Head Global Medical Affairs Fertility Merck

Speaker Logo Hubert Bland Country Medical Chair and Medical Head Diabetes and Cardiovascular Sanofi

Speaker Logo Ludovic Hacopian Worldwide MSL and Field Effectiveness Head BMS

Speaker Logo Emma Booth European Medical Head of Strategy and Operations Amgen

00:00
-
00:00
Maintain your external authenticity as your internal importance increases
  • Fuse your new strategic role with the scientific base that has already incurred increasing Medical influence
  • Bring together internal functions and destroy silos to devise strategy that is in the best interests of the patient
  • Evolve medical through increased external interaction and improve the image of pharma as a consequence

Speaker Logo Monica de Abadal Vice President Global Medical Affairs Services Ipsen

00:00
-
00:00
A flexible and pragmatic Medical operating model to amplify stakeholder value
  • Build a framework that achieves global and regional objectives on a country level, allowing for flexibility and local tailoring
  • Maximise external value: prioritise projects that will make the biggest difference to external stakeholder
  • Centre your new strategy around core strengths that will bring the best out of your Medical team

Speaker Logo Mauricio Silva de Lima VP Head of Medical Affairs Europe Roche

00:00
-
00:00
ROUNDTABLE DISCUSSIONS
  1. Determine the best place for Medical to sit. Under commercial, under clinical or by itself?
  2. What are the skills and expertise needed to face new Med Affairs objectives and challenges?
  3. Gaining drug approval: Is real-world the real deal?
  4. How to best communicate your data to external stakeholders and gain insights in return
  5. What does AI offer Medical in the future?
  6. How to maintain MSL authenticity under commercial pressures
ACHIEVING VALUE: DATA INSIGHTS AND REAL-WORLD INFLUENCE
00:00
-
00:00
From volume to valued data: collect evidence in the most effective way
  • Develop an outcome-orientated model for data collection and analysis
  • Shift your mindset from ‘deterministic to probabilistic’ and fall in line with clinical intervention procedures
  • Learn how another industry drives success with effective data analysis and performance

Speaker Logo Adam Hill Chief Medical Officer McLaren

00:00
-
00:00
The future of Real-World Evidence: optimising outcomes
  • Responding to a regulatory model that will gain earlier approval with less data from phase 3
  • Use real-world data to plan your route to a value-based healthcare system
  • Be more efficient in your research studies

Speaker Logo Mike Spencer Head of RWE, EMEA Janssen

00:00
-
00:00
Use digital to bring you closer to external stakeholders with data collection and dissemination
  • Gather real-time patient data for the most reliable study results
  • Communicate your data to HCPs and KOLs most effectively for maximum external engagement
  • Use digital platforms to share patient data with your colleagues in a compliant way

Speaker Logo Felix Jackson Founder medCrowd

MSLS: PARTNERS TO PHARMA, PHYSICIANS AND PATIENTS
00:00
-
00:00
Turn your MSLs into Medical Science Leaders
  • Identify the best candidates when recruiting the external faces of your brand
  • Upgrade your MSL team with developed business skills to complement their medical knowledge
  • See how a leading medical company have developed their MSL Centre of Excellence to instil a culture of quality

Speaker Logo Martina Muttke Head of International Affairs Shire

00:00
-
00:00
PANEL: Continue to build trust between pharma and physicians through evidence based interactions
  • Keep your MSLs on-message in off-label discussions to collect core insights from wide ranging discussions
  • Teach your MSLs how to create open and frank dialogues with KOLs and HCPs that will lead to the most productive conversations
  • Gain a strategic advantage before market access by discussing drugs in clinical phases to understand what the market needs

Speaker Logo Kumaran Krishnan Associate Director MSL and Digital Transformation Teva

Speaker Logo Gundula Schneidewind Managing Director Belgium Takeda

Speaker Logo David Montgomery Vice President Global Science Exchange Pfizer Oncology

00:00
-
00:00
Own the Medical Narrative and drive partnership
  • Understand the evolution of measures of Field Medical value; from counting calls to unlocking the true value of MSL relations through qualitative methods
  • Create a cohesive framework that inspires your MSLs to deliver on global visions through differing, country dependent methods
  • Elevate the status of field medical from resource to strategic partner.

Speaker Logo Victoria Ho WW Field Medical & Communications Lead Bristol-Myers Squibb

00:00
-
00:00
*The “value” of Medical Affairs to the medical community*
  • Create a ‘value-added service’ for physicians through exclusively medical activities
  • Bring value to both customers and clinicians though enhanced communication processes
  • Build valuable partnerships where medical can have a leading role in the long term

Speaker Logo Pam Bacon Executive Director Medical Affairs Celgene

00:00
-
00:00
Think Globally, Act Locally: Build your big picture one pixel at a time
  • Develop a Medical team that can understand their role in the global vision of the company
  • Give your team freedom to act depending on local issues to be most effective in their region
  • Align your team as a strategic partner from top to bottom to become a true mission-critical function

Sanofi Sandra Silvestri Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit Sanofi

00:00
-
00:00
Promoting the patient voice in evidence generation and global market access planning
  • Overview of real-world challenges and considerations for use
  • Regulator and payer perspectives on patient-centric data in decision-making
  • Highly successful strategies for leveraging the patient voice in RWE research

Speaker Logo Parexel

Download the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown